Gene Editing Study highlights COVID-19 vaccine safety among children Posted on February 23, 2023 by Editorial Staff Researchers evaluate COVID-19 vaccine-associated serious adverse events following immunization among five- to 17-year-old children. Share on FacebookTweetFollow us Editorial Staff Following third dose of BNT162b2, adverse events increased in those with prior COVID-19 Apolipoprotein E4 promotes the development of Alzheimer’s disease
